Latest news
Radiopharmaceutical may benefit patients with metastatic prostate cancer sooner - Medical XpressMedical Xpress · Fri, 07 Aug 2026 17:20:05 GMTTheriva Biologics Doses First Patient in VIRAGE2 Trial of VCN-01 for Metastatic Pancreatic Cancer - The Clinical Trial VanguardThe Clinical Trial Vanguard · Fri, 07 Aug 2026 06:44:00 GMTApproval of Pluvicto® for Metastatic Hormone-Sensitive Prostate Cancer - Oliver Sartor - urotoday.comurotoday.com · Thu, 06 Aug 2026 19:44:56 GMTScientists identify tumor-secreted protein that promotes lung metastasis in cancer patients - Cornell ChronicleCornell Chronicle · Thu, 06 Aug 2026 16:15:52 GMTMost histotripsy procedures used for metastatic disease treatment - AuntMinnieAuntMinnie · Wed, 05 Aug 2026 16:16:48 GMTFDA expands Pluvicto label, making it available to most metastatic prostate cancer patients - Endpoints NewsEndpoints News · Mon, 03 Aug 2026 15:26:00 GMTNovartis’ Pluvicto approved by FDA for metastatic hormone-sensitive prostate cancer - PMLiVEPMLiVE · Mon, 03 Aug 2026 11:55:35 GMTFDA Approves Lutetium Lu 177 Vipivotide Tetraxetan Plus ARPI for Prostate Cancer - Oncology News CentralOncology News Central · Mon, 03 Aug 2026 10:27:38 GMT